» Articles » PMID: 19204768

Cross-sectional Epidemiological Study to Evaluate the Cardiovascular Profile of a Cohort of Blood Donors

Overview
Journal Blood Transfus
Specialty Hematology
Date 2009 Feb 11
PMID 19204768
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cardiovascular diseases are among the most frequent causes of mortality and morbidity in industrialised countries. The identification of subjects at high risk of cardiovascular diseases is one of the main aims of individual primary prevention programmes and is the essential background for instituting interventions aimed at reducing modifiable risk factors, from lifestyle changes to pharmacological interventions. DONORS AND METHOD: In order to evaluate the absolute global risk of cardiovascular disease in the population of blood donors of the Transfusion and Immunohaematology Centre of the Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena of Milan, we used the absolute global cardiovascular risk (CVR) score of the Progetto Cuore. Between September 2004 and June 2006, 11,093 blood donors were evaluated for their suitability for donating blood. The criteria for inclusion in the calculation of the individual values of the absolute global CVR score were: age between 35 and 65 years old, fasted for at least 12 hours, and no previous reported or diagnosed cardiovascular episodes. Each donor was also asked to provide written informed consent to participation in the study. THE POPULATION OF BLOOD DONORS WAS DIVIDED INTO FOUR GROUPS ACCORDING TO THEIR CVR SCORE: CVR < 3%, CVR between 3% and 10%, CVR between 10% and 20%; CVR above 20%. The characteristics of the population were analysed subdividing the subjects according to age and gender.

Results: Although most of the blood donors belonged to the group with low CVR, it was nevertheless possible to identify a group of donors with high CVR.

Conclusions: It is to be hoped that CVR is calculated ever more widely in the population of blood donors in order to identify individuals at high CVR and also with the aim of reducing the levels of risk factors in the population with low or moderate CVR.

Citing Articles

Machine Learning Approach for Cardiovascular Death Prediction among Nonalcoholic Steatohepatitis (NASH) Liver Transplant Recipients.

Fatemi Y, Nikfar M, Oladazimi A, Zheng J, Hoy H, Ali H Healthcare (Basel). 2024; 12(12).

PMID: 38921280 PMC: 11202858. DOI: 10.3390/healthcare12121165.


Homocysteine and education but not lipoprotein (a) predict estimated 10-year risk of cardiovascular disease in blood donors: a community based cross-sectional study.

Vadini F, Santilli F, Casalini G, dellIsola M, Iuliani O, DArdes D BMC Cardiovasc Disord. 2019; 19(1):177.

PMID: 31349819 PMC: 6660663. DOI: 10.1186/s12872-019-1157-5.


The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program.

Capuzzo E, Bonfanti C, Frattini F, Montorsi P, Turdo R, Previdi M Ann Transl Med. 2016; 4(10):189.

PMID: 27294085 PMC: 4885887. DOI: 10.21037/atm.2016.03.58.


Evaluation of cardiovascular risk in blood donors: results of the CARDIORISK study in the Parma Transfusion Service.

DellAnna P, Adorni D, Bernuzzi G, Cantarelli S, Cepparulo A, Cocchi T Blood Transfus. 2010; 8(3):155-8.

PMID: 20671874 PMC: 2906184. DOI: 10.2450/2009.0097-09.

References
1.
PEARSON T . Population benefits of cholesterol reduction: epidemiology, economics, and ethics. Am J Cardiol. 2000; 85(12A):20E-3E. DOI: 10.1016/s0002-9149(00)00947-4. View

2.
Anderson K, Wilson P, Odell P, Kannel W . An updated coronary risk profile. A statement for health professionals. Circulation. 1991; 83(1):356-62. DOI: 10.1161/01.cir.83.1.356. View

3.
Grundy S, Pasternak R, Greenland P, Smith Jr S, Fuster V . Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999; 100(13):1481-92. DOI: 10.1161/01.cir.100.13.1481. View

4.
De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J . European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by.... Eur J Cardiovasc Prev Rehabil. 2003; 10(4):S1-S10. DOI: 10.1097/01.hjr.0000087913.96265.e2. View

5.
Giampaoli S, Palmieri L, Mattiello A, Panico S . Definition of high risk individuals to optimise strategies for primary prevention of cardiovascular diseases. Nutr Metab Cardiovasc Dis. 2005; 15(1):79-85. DOI: 10.1016/j.numecd.2004.12.001. View